All together, our data support the suggestion that DNAJB3 can potentially play a protective role against obesity, and thus targeting DNAJB3 may have a potential therapeutic benefit for the control and management of obesity and insulin resistance. The gene discussed is DNAJB3; the disease is Insulin resistance.